设计,合成和评估新型卡博林-三混合物作为有前途的抗疟疾药物

Ajay Kishor Kushawaha1, Rohini Nandi2, Arvind Kumar Jaiswal1

  • 1Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute BS, 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, Uttar Pradesh, India.

概括

新的卡博林-三醇化合物显示出强大的抗疟疾活性,对抗虫寄生虫. 化合物15k在体内表现出强烈的疗效和有利的药理动力学,这表明口服药物开发的潜力.